vs

Side-by-side financial comparison of KOSS CORP (KOSS) and NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). Click either name above to swap in a different company.

NEUROONE MEDICAL TECHNOLOGIES Corp is the larger business by last-quarter revenue ($2.9M vs $2.9M, roughly 1.0× KOSS CORP). KOSS CORP runs the higher net margin — -19.8% vs -49.7%, a 29.9% gap on every dollar of revenue. On growth, NEUROONE MEDICAL TECHNOLOGIES Corp posted the faster year-over-year revenue change (-11.7% vs -19.6%). KOSS CORP produced more free cash flow last quarter ($-1.1M vs $-3.2M). Over the past eight quarters, NEUROONE MEDICAL TECHNOLOGIES Corp's revenue compounded faster (44.9% CAGR vs 4.2%).

Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.

NeuroOne Medical Technologies Corp is a medical technology company specializing in the development and commercialization of diagnostic and therapeutic neurological devices for conditions including epilepsy, movement disorders, and chronic pain. Its core products include minimally invasive cortical monitoring electrodes and neurostimulation systems, primarily serving neurology and neurosurgical care providers across North America.

KOSS vs NMTC — Head-to-Head

Bigger by revenue
NMTC
NMTC
1.0× larger
NMTC
$2.9M
$2.9M
KOSS
Growing faster (revenue YoY)
NMTC
NMTC
+7.9% gap
NMTC
-11.7%
-19.6%
KOSS
Higher net margin
KOSS
KOSS
29.9% more per $
KOSS
-19.8%
-49.7%
NMTC
More free cash flow
KOSS
KOSS
$2.1M more FCF
KOSS
$-1.1M
$-3.2M
NMTC
Faster 2-yr revenue CAGR
NMTC
NMTC
Annualised
NMTC
44.9%
4.2%
KOSS

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
KOSS
KOSS
NMTC
NMTC
Revenue
$2.9M
$2.9M
Net Profit
$-565.4K
$-1.4M
Gross Margin
29.0%
54.2%
Operating Margin
-35.5%
-59.0%
Net Margin
-19.8%
-49.7%
Revenue YoY
-19.6%
-11.7%
Net Profit YoY
-700.6%
-180.5%
EPS (diluted)
$-0.06
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KOSS
KOSS
NMTC
NMTC
Q4 25
$2.9M
$2.9M
Q3 25
$4.1M
$2.7M
Q2 25
$3.1M
$1.7M
Q1 25
$2.8M
$1.4M
Q4 24
$3.6M
$3.3M
Q3 24
$3.2M
$272.3K
Q2 24
$2.9M
$825.8K
Q1 24
$2.6M
$1.4M
Net Profit
KOSS
KOSS
NMTC
NMTC
Q4 25
$-565.4K
$-1.4M
Q3 25
$243.7K
$-1.6M
Q2 25
$-232.7K
$-1.5M
Q1 25
$-316.7K
$-2.3M
Q4 24
$94.1K
$1.8M
Q3 24
$-419.5K
Q2 24
$-110.4K
$-2.8M
Q1 24
$-313.8K
$-2.9M
Gross Margin
KOSS
KOSS
NMTC
NMTC
Q4 25
29.0%
54.2%
Q3 25
40.0%
55.8%
Q2 25
36.0%
53.9%
Q1 25
39.0%
55.6%
Q4 24
39.5%
58.9%
Q3 24
36.6%
51.8%
Q2 24
40.4%
34.1%
Q1 24
31.9%
28.3%
Operating Margin
KOSS
KOSS
NMTC
NMTC
Q4 25
-35.5%
-59.0%
Q3 25
-1.1%
-50.0%
Q2 25
-14.2%
-111.2%
Q1 25
-18.7%
-193.3%
Q4 24
-4.0%
52.3%
Q3 24
-19.9%
Q2 24
-11.0%
-338.3%
Q1 24
-23.1%
-209.5%
Net Margin
KOSS
KOSS
NMTC
NMTC
Q4 25
-19.8%
-49.7%
Q3 25
6.0%
-59.1%
Q2 25
-7.5%
-88.5%
Q1 25
-11.4%
-163.8%
Q4 24
2.6%
54.5%
Q3 24
-13.1%
Q2 24
-3.8%
-335.1%
Q1 24
-11.9%
-207.3%
EPS (diluted)
KOSS
KOSS
NMTC
NMTC
Q4 25
$-0.06
$-0.03
Q3 25
$0.03
$-0.05
Q2 25
$-0.02
$-0.03
Q1 25
$-0.03
$-0.07
Q4 24
$0.01
$0.06
Q3 24
$-0.05
Q2 24
$-0.01
$-0.10
Q1 24
$-0.03
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KOSS
KOSS
NMTC
NMTC
Cash + ST InvestmentsLiquidity on hand
$15.5M
$3.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$30.3M
$6.4M
Total Assets
$36.8M
$8.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KOSS
KOSS
NMTC
NMTC
Q4 25
$15.5M
$3.6M
Q3 25
$16.5M
$6.6M
Q2 25
$15.7M
$8.0M
Q1 25
$13.0M
$1.3M
Q4 24
$9.7M
$1.1M
Q3 24
$11.9M
$1.5M
Q2 24
$14.9M
$1.6M
Q1 24
$9.9M
$2.4M
Stockholders' Equity
KOSS
KOSS
NMTC
NMTC
Q4 25
$30.3M
$6.4M
Q3 25
$30.9M
$7.1M
Q2 25
$30.6M
$8.2M
Q1 25
$30.7M
$1.1M
Q4 24
$31.0M
$2.9M
Q3 24
$30.8M
$822.0K
Q2 24
$31.1M
$3.0M
Q1 24
$31.1M
$3.9M
Total Assets
KOSS
KOSS
NMTC
NMTC
Q4 25
$36.8M
$8.6M
Q3 25
$37.7M
$10.8M
Q2 25
$37.2M
$10.8M
Q1 25
$37.3M
$4.5M
Q4 24
$37.4M
$6.5M
Q3 24
$38.1M
$5.4M
Q2 24
$37.2M
$4.9M
Q1 24
$37.6M
$5.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KOSS
KOSS
NMTC
NMTC
Operating Cash FlowLast quarter
$-760.8K
$-3.1M
Free Cash FlowOCF − Capex
$-1.1M
$-3.2M
FCF MarginFCF / Revenue
-37.5%
-109.1%
Capex IntensityCapex / Revenue
10.9%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-546.7K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KOSS
KOSS
NMTC
NMTC
Q4 25
$-760.8K
$-3.1M
Q3 25
$762.6K
$-1.5M
Q2 25
$-534.9K
$-1.5M
Q1 25
$370.4K
$-56.1K
Q4 24
$-252.0K
$208.0K
Q3 24
$201.6K
$-11.0M
Q2 24
$-174.0K
$-2.4M
Q1 24
$328.6K
$-2.2M
Free Cash Flow
KOSS
KOSS
NMTC
NMTC
Q4 25
$-1.1M
$-3.2M
Q3 25
$761.5K
Q2 25
$-541.8K
$-1.5M
Q1 25
$306.2K
Q4 24
$-314.3K
$183.6K
Q3 24
$-155.6K
$-11.1M
Q2 24
$-174.8K
$-2.4M
Q1 24
$269.3K
$-2.2M
FCF Margin
KOSS
KOSS
NMTC
NMTC
Q4 25
-37.5%
-109.1%
Q3 25
18.7%
Q2 25
-17.6%
-89.0%
Q1 25
11.0%
Q4 24
-8.8%
5.6%
Q3 24
-4.9%
-4088.4%
Q2 24
-6.0%
-287.6%
Q1 24
10.2%
-160.2%
Capex Intensity
KOSS
KOSS
NMTC
NMTC
Q4 25
10.9%
1.4%
Q3 25
0.0%
Q2 25
0.2%
2.8%
Q1 25
2.3%
Q4 24
1.8%
0.7%
Q3 24
11.2%
44.1%
Q2 24
0.0%
1.8%
Q1 24
2.3%
2.3%
Cash Conversion
KOSS
KOSS
NMTC
NMTC
Q4 25
Q3 25
3.13×
Q2 25
Q1 25
Q4 24
-2.68×
0.12×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons